Skip to main content
. 2021 Aug 13;7(8):e07784. doi: 10.1016/j.heliyon.2021.e07784

Figure 7.

Figure 7

‘Test’ active drugs at the hSERT aligned to the designed pharmacophore in Figure 6C. Their 2D structure and 5HT release (EC50) and uptake inhibition (IC50) activities are associated to each compound. The small orange circles on the compounds represent the matched feature pairs that aligned to the pharmacophore. To our knowledge, there is no data on Br-dragonfly, although the pharmacophore fit predicts it may be active at the hSERT.